Information  X 
Enter a valid email address

Arix Bioscience PLC 0.001P (ARIX)

Date Time Source Announcement
16 Apr 2019 7:00 am
PRN
Autolus announces closing of public offering
11 Apr 2019 7:00 am
PRN
Autolus announces pricing of public offering
09 Apr 2019 7:00 am
PRN
Autolus announces launch of proposed public offering
02 Apr 2019 7:08 am
PRN
Aura completes $40 million Series D financing
01 Apr 2019 6:10 pm
PRN
Autolus presents initial AUTO1 data at AACR
28 Mar 2019 7:00 am
PRN
Annual Results for the year ended 31 December 2018
  7:00 am
PRN
Board changes
26 Mar 2019 10:17 am
PRN
Autolus hosts R&D day and provides update on AUTO3
20 Mar 2019 12:23 pm
PRN
Notice of Results
18 Mar 2019 7:00 am
PRN
Arix co-leads $63m Series B investment round for Imara
19 Feb 2019 12:12 pm
PRN
Autolus announces updated results from CARPALL trial
  7:00 am
PRN
Management and Board changes
14 Feb 2019 7:00 am
PRN
Harpoon closes initial public offering
08 Feb 2019 7:09 am
PRN
Harpoon prices Nasdaq IPO
01 Feb 2019 10:38 am
PRN
Total Voting Rights
29 Jan 2019 2:25 pm
PRN
Update on Harpoon proposed IPO in the United States
03 Jan 2019 7:00 am
PRN
Issue of Ordinary Shares and Total Voting Rights
28 Dec 2018 7:00 am
PRN
Harpoon announces proposed public offering in the US
11 Dec 2018 7:00 am
PRN
Arix appoints Dr Christian Schetter as EIR
03 Dec 2018 7:00 am
PRN
Autolus announces update on AUTO4 and AUTO5 programmes
  7:00 am
PRN
Autolus presents initial AUTO3 clinical data at ASH
15 Nov 2018 7:00 am
PRN
Positive Phase 1 clinical trial results
12 Nov 2018 7:00 am
PRN
Arix invests in $70m Harpoon Series C investment round
02 Nov 2018 11:33 am
PRN
Autolus Therapeutics to Present New Data at the ASH
30 Oct 2018 2:11 pm
PRN
Aura Biosciences reports positive Phase 1b/2 data
24 Oct 2018 7:00 am
PRN
LogicBio announces closing of initial public offering
19 Oct 2018 7:00 am
PRN
LogicBio prices Nasdaq IPO
10 Oct 2018 7:00 am
PRN
Update on LogicBio proposed IPO in the United States
01 Oct 2018 7:00 am
PRN
Co-leads $58 million Series A for VelosBio
26 Sep 2018 7:00 am
PRN
LogicBio files registration for proposed IPO in the US
18 Sep 2018 2:00 pm
PRN
Update on Iterum Therapeutics Phase 3 trials
12 Sep 2018 4:30 pm
PRN
Announces Board Changes
10 Sep 2018 4:24 pm
PRN
Holding(s) in Company
04 Sep 2018 7:00 am
PRN
Changes announced to executive team
17 Aug 2018 1:01 pm
PRN
Holdings in Company and Lock-in Agreement
10 Aug 2018 7:01 am
PRN
Positive clinical progression in Group Businesses
  7:00 am
PRN
Artios completes �65m Series B investment round
06 Aug 2018 7:00 am
PRN
Arix Bioscience announces first VIPE investment
30 Jul 2018 7:00 am
PRN
Interim Results for the Six Months Ended 30 June 2018
25 Jul 2018 4:41 pm
PRN
Notice of Results
02 Jul 2018 1:16 pm
PRN
Total Voting Rights
26 Jun 2018 5:30 pm
PRN
Autolus annouces closing of IPO
22 Jun 2018 7:07 am
PRN
Autolus Announces Pricing of Initial Public Offering
21 Jun 2018 10:22 am
PRN
Issue of Shares, Total Voting Rights & PDMR Notification
11 Jun 2018 4:23 pm
PRN
Director/PDMR Shareholding
08 Jun 2018 11:36 am
PRN
Update on Autolus proposed NASDAQ IPO
31 May 2018 2:00 pm
PRN
Lord John Hutton steps down from Board of Directors
30 May 2018 4:13 pm
PRN
Iterum Therapeutics plc Closes Initial Public Offering
25 May 2018 7:19 am
PRN
Iterum Therapeutics plc Prices Initial Public Offering
17 May 2018 12:29 pm
RNS
Result of AGM
  7:00 am
RNS
Update on Iterum proposed NASDAQ IPO
08 May 2018 7:00 am
RNS
Autolus Files for Proposed US IPO
02 May 2018 10:10 am
RNS
Arix notes Iterum?s proposed US IPO
23 Apr 2018 7:00 am
RNS
Annual Results 2017
16 Apr 2018 7:25 am
RNS
Notice of Annual Results
05 Apr 2018 7:00 am
RNS
Arix to present at HC Wainwright on 10 April
04 Apr 2018 9:01 am
RNS
Holding(s) in Company
  9:00 am
RNS
Total Voting Rights
26 Mar 2018 1:40 pm
RNS
Holding(s) in Company
  12:31 pm
RNS
Arix notes positive Ph2b COPD data from Verona
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t